Milestone Pharmaceuticals, Inc. (MIST): Kapitalizatsiya va daromad nisbati

Milestone Pharmaceuticals, Inc. (MIST) kompaniyasining korporativ logotipi

Spekulyativ kapitalga bog'liqlik va FDA tasdiqlashidagi qiyinchiliklar Milestone Pharmaceuticals (MIST) kompaniyasiga salbiy ta'sir ko'rsatmoqda, u takikardiyaning o'tkir davolash uchun etripamil burun sprey-lari bilan noyob nishani egallamoqda. Narx/savdo koeffitsiyenti dinamikasi joriy sikl bosqichini aks ettiradi, bunda 34.50 ko'rsatkichi maqsadli daraja vazifasini o'taydi. Bozor kapitalizatsiyasi klinik muhitdan tashqarida favqulbosi yordamga muhtoj bo'lgan bemorlar va kardiologlarning kelgusidagi talabiga bog'liq.

MIST milestonepharma.com Kapitalizatsiyaning daromadga nisbati (04.07.2022 - 13.11.2026)

Milestone Pharma (MIST) kompaniyasining tahliliy kesimlari

- joriy kotirovkalar va o'rtacha qiymat prognozi:
Birja narxi milestonepharma.com|MIST - Maqsadli narxlar grafigi
- birja kapitallashuvi ma'lumotlari:
Bozor kapitallashuvi Milestone Pharma|MIST - Korxona qiymati
- biznesning balans baholash tafsilotlari:
Bitta aksiya hisobiga sof aktivlar qiymati Milestone Pharmaceuticals|MIST - Kompaniyaning sof aktivlari|Balans qiymatiga nisbatan bozor qiymati milestonepharma.com|MIST - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Jamlagan qarzning xususiy kapitalga nisbati Milestone Pharmaceuticals|MIST - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Milestone Pharmaceuticals Inc|MIST - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Milestone Pharma|MIST - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Milestone Pharmaceuticals|Tezkor likvidlik ko‘rsatkichi milestonepharma.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
MIST - Sof foyda|Prognoz qilingan kelajakdagi foyda Milestone Pharmaceuticals|MIST - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Milestone Pharmaceuticals, Inc.|MIST - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Milestone Pharma|MIST - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Milestone Pharmaceuticals|MIST - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati milestonepharma.com|MIST - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Milestone Pharmaceuticals
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
MIST - Daromad va sotish hajmi|Kompaniyaning kelajakdagi sotish hajmi milestonepharma.com|MIST - P/S multiplikatori|Forvard P/S multiplikatori Milestone Pharma
Kompaniyaning umumiy tahlili:MIST milestonepharma.com
Milestone Pharmaceuticals Inc yetakchi tovari

P/S koeffitsienti bozor kapitalizatsiyasini generatsiya qilingan savdo hajmi bilan solishtiradi, bu esa joriy foyda yoki zararlardan mustaqil ravishda biznesni baholash imkonini beradi. Milestone Pharmaceuticals (MIST) uchun, uning qiymati kardiologiya biotexnologiyalari sohasidagi boshqaruv tajribasiga va FDA bosqichlarining shaffofligiga bog'liq bo'lgani sababli, daromadga asoslangan ushbu baholash kelgusidagi tijorat mahsulotining ishga tushirilishiga nisbatan bozor kutganlarini ko'rsatuvchi indikator vazifasini o'taydi.

Milestone Pharmaceuticals raqobatchilari

REGN - Sotuvga nisbatan narx|Narxning daromadga nisbati iRhythm IRTC|LNTH: Kapitalizatsiya va daromad nisbati|Mineralys Therapeutics Inc - P/S multiplikatori|Sotuvga nisbatan narx Heartflow Inc|KMTS (Kestra Medical Technologies) - Kapitalizatsiyaning daromadga nisbati|esperion.com - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Amarin|Anteris Technologies Ltd - Narxning sotuvga nisbati|P/S multiplikatori TNYA|CVRX (CVRx Inc) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori CRDL (Cardiol Therapeutics Inc.)|P/S multiplikatori heartbeam.com BEAT|TENX - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ADGM (Adagio Medical Holdings, Inc.)|BioCardia, Inc (BCDA) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Catheter Precision Corporation|ABIO (ARCA Biopharma Inc) - P/S multiplikatori|P/S multiplikatori Acasti|P/S multiplikatori AVTE|Kapitalizatsiyaning daromadga nisbati vervetx.com VERV|P/S multiplikatori WINT (Windtree Therapeutics, Inc.)